Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Compliance and acceptance in antidepressant treatment
Autore:
Demyttenaere, K;
Indirizzi:
Univ Hosp Gasthuisberg, Dept Psychiat, B-3000 Louvain, Belgium Univ Hosp Gasthuisberg Louvain Belgium B-3000 t, B-3000 Louvain, Belgium
Titolo Testata:
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
, volume: 5, anno: 2001, supplemento:, 1
pagine: S29 - S35
SICI:
1365-1501(200106)5:<S29:CAAIAT>2.0.ZU;2-Z
Fonte:
ISI
Lingua:
ENG
Soggetto:
PRIMARY-CARE; CLINICAL-TRIAL; GENERAL-PRACTICE; WITHDRAWAL; DISCONTINUATION; NONCOMPLIANCE; MEDICATION; THERAPY; ADHERENCE; LITHIUM;
Keywords:
primary care; compliance; antidepressants; major depression; adherence;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
46
Recensione:
Indirizzi per estratti:
Indirizzo: Demyttenaere, K Univ Hosp Gasthuisberg, Dept Psychiat, Herestr 49, B-3000 Louvain, Belgium Univ Hosp Gasthuisberg Herestr 49 Louvain Belgium B-3000
Citazione:
K. Demyttenaere, "Compliance and acceptance in antidepressant treatment", INT J PSYC, 5, 2001, pp. S29-S35

Abstract

Poor compliance with antidepressant medication is widespread in both primary care and psychiatric practice, and is a major obstacle to the effective management of depression. It is often believed that adverse events and a lack of efficacy associated with inappropriate prescribing of older antidepressants are common reasons why patients discontinue treatment prematurely. However, appropriate prescribing of effective and well-tolerated antidepressants does not necessarily guarantee compliance. A patient's core beliefs and attitudes to treatment also influence the chances of successful management, and studies have shown that patients harbour many unfounded beliefs relating to antidepressant medications and their use. The prescribing physicianis therefore duty bound not only to ensure that they chose an effective antidepressant with minimal side-effects and prescribe it according to treatment guidelines, but that they actively explore the patient's beliefs and attitudes at the time of treatment. Addressing common misconceptions about antidepressant medications, and undertaking a structured follow-up, have beenshown both to enhance compliance and improve treatment outcomes. The choice of newer, more selective antidepressants results in a higher number of patients achieving at least one month of treatment. The choice of a drug witha once-daily treatment regimen (drugs with a longer half-life) and with a low risk for discontinuation symptoms if doses are occasionally missed is also warranted.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/20 alle ore 08:03:24